Drug profile · INN
toripalimab-tpzi
LOQTORZI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
toripalimab-tpzi (LOQTORZI) is an FDA-listed pharmaceutical active ingredient. Associated with Coherus Oncology. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN toripalimab-tpzi
Brand LOQTORZI
Route INJECTION
Formulation INJECTABLE
Originator Coherus Oncology
Frequently asked questions
What is toripalimab-tpzi?
toripalimab-tpzi (LOQTORZI) is an FDA-listed pharmaceutical active ingredient. Associated with Coherus Oncology. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for toripalimab-tpzi?
LOQTORZI is a marketed brand name for toripalimab-tpzi. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of toripalimab-tpzi?
toripalimab-tpzi has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.